March 2, 2020 / 12:48 PM / a month ago

BRIEF-ImmunoPrecise Announces Artificial Intelligence Collaboration With EVQLV

March 2 (Reuters) - Immunoprecise Antibodies Ltd:

* IMMUNOPRECISE ANNOUNCES ARTIFICIAL INTELLIGENCE COLLABORATION WITH EVQLV TO ACCELERATE VACCINE AND ANTIBODY DISCOVERY FOR SARS-COV-2 CORONAVIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below